methotrexate has been researched along with Hepatic Veno Occlusive Disease in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 6 (37.50) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albertsen, BK; De Pietri, S; Frandsen, TL; Grell, K; Lähteenmäki, PM; Nersting, J; Nielsen, SN; Nilsson, D; Nystad, TA; Rosthøj, S; Schmiegelow, K; Toksvang, LN; Wehner, PS | 1 |
| Decorti, G; Franca, R; Londero, M; Rabusin, M; Stocco, G; Verzegnassi, F | 1 |
| Kent, MW; McNamara, JM; McNerney, KO; Vasquez, JC | 1 |
| Diamantidis, MD; Girtovitis, F; Hatzitolios, A; Kaiafa, G; Kontoninas, Z; Ntaios, G; Papadopoulos, A; Saouli, Z; Savopoulos, C | 1 |
| Bleyer, A; Broxson, E; Gaynon, PS; Heerema, NA; Hutchinson, R; La, M; Masterson, M; Matloub, Y; Sather, H; Sorrell, AD; Stork, LC; Yanofsky, R | 1 |
| French, S; Gershman, G; Tang, W; Ziring, D | 1 |
| Kallianpur, AR | 1 |
| Conte, ML; Indolfi, P; La Manna, A; Locatelli, F; Nobili, B; Perrotta, S; Rossi, F | 1 |
| Barnett, MJ; Klingemann, HG; Nantel, SH; Phillips, GL; Reece, DE; Shepherd, JD; Spinelli, JJ; Sutherland, HJ | 1 |
| Brodsky, I; Bulova, S; Crilley, P; Marks, DI; Styler, MJ; Topolsky, D | 1 |
| Avalos, B; Biggs, J; Brodsky, I; Copelan, E; Crilley, P; Downs, K; Marks, DI; Moul, J; Penza, S; Sabol, P; Styler, MJ; Szer, J; Topolsky, D | 1 |
| Blay, JY; Bonnotte, B; Bourhis, JH; Burdiles, AM; Caignard, A; Carayol, G; Chehimi, J; Chouaib, S; Dietrich, PY; Hayat, M; Ibrahim, A; Kubin, M; Pardoux, C; Pico, JL; Robinet, E | 1 |
| Hirabayashi, N; Ikeda, Y; Ishida, A; Matsuoka, S; Moriki, T; Okamoto, S; Wakui, M; Watanabe, R | 1 |
| Kabisch, H; Kröger, N; Krüger, W; Renges, H; Schetelig, J; Schrum, J; Siegert, W; Stute, N; Zabelina, T; Zander, AR | 1 |
| Essell, JH; Halvorson, RD; Harman, GS; Johnson, RA; Rubinsak, JR; Snyder, MJ; Thompson, JM | 1 |
| Deeg, HJ; Luk, K; Shulman, HM; Shuman, WB; Storb, R | 1 |
3 review(s) available for methotrexate and Hepatic Veno Occlusive Disease
| Article | Year |
|---|---|
Pharmacogenomic approaches for tailored anti-leukemic therapy in children.
Topics: Alkaloids; Antineoplastic Agents; Benzamides; Child; Glucocorticoids; Hepatic Veno-Occlusive Disease; Humans; Imatinib Mesylate; Mercaptopurine; Methotrexate; Nucleotides; Pharmacogenetics; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Thioguanine; Vincristine | 2013 |
Genomic screening and complications of hematopoietic stem cell transplantation: has the time come?
Topics: Alleles; Genetic Linkage; Genetic Predisposition to Disease; Genome; Genotype; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Iron; Liver; Lung Diseases; Mass Screening; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Models, Biological; Models, Chemical; Oligonucleotide Array Sequence Analysis; Oxidants; Polymorphism, Genetic; Renal Insufficiency; Risk Factors; Time Factors; Transplantation Conditioning; Treatment Outcome | 2005 |
Regimen-related acute toxicities: pathophysiology, risk factors, clinical evaluation and preventive strategies.
Topics: Acute Disease; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Carboplatin; Carmustine; Clinical Trials, Phase I as Topic; Combined Modality Therapy; Cyclophosphamide; Cystitis; Female; Hepatic Veno-Occlusive Disease; Humans; Incidence; Leukemia, Myeloid; Liver; Lung Diseases, Interstitial; Lymphoma; Male; Methotrexate; Retrospective Studies; Risk Factors; Whole-Body Irradiation | 1994 |
3 trial(s) available for methotrexate and Hepatic Veno Occlusive Disease
| Article | Year |
|---|---|
Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Drug Interactions; Female; Hepatic Veno-Occlusive Disease; Humans; Infant; Kaplan-Meier Estimate; Maintenance Chemotherapy; Male; Mercaptopurine; Methotrexate; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proportional Hazards Models | 2017 |
Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Hepatic Veno-Occlusive Disease; Humans; Hypertension, Portal; Infant; Injections, Spinal; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thioguanine | 2010 |
Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving busulfan/cyclophosphamide.
Topics: Actuarial Analysis; Adult; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Female; Follow-Up Studies; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Methylprednisolone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors; Whole-Body Irradiation | 1992 |
10 other study(ies) available for methotrexate and Hepatic Veno Occlusive Disease
| Article | Year |
|---|---|
Sinusoidal Obstruction Syndrome During Maintenance Therapy for Acute Lymphoblastic Leukemia With 6-Mercaptopurine and Methotrexate: A Pediatric Case Report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biopsy; Child; Drug Interactions; Hepatic Veno-Occlusive Disease; Humans; Maintenance Chemotherapy; Male; Mercaptopurine; Methotrexate; Multimodal Imaging; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2017 |
Veno-occlusive disease of the liver during induction therapy for acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; Female; Fibrinolytic Agents; Hepatic Veno-Occlusive Disease; Humans; Liver; Marfan Syndrome; Methotrexate; Middle Aged; Polydeoxyribonucleotides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Vincristine | 2008 |
Role of macrophages and stellate cells in the pathogenesis of veno-occlusive disease: an electron microscopic case study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Female; Hepatic Veno-Occlusive Disease; Humans; Liver; Macrophages; Mercaptopurine; Methotrexate; Microscopy, Electron; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine | 2003 |
Membranous glomerulopathy in children given allogeneic hematopoietic stem cell transplantation.
Topics: Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Edema; Glomerulonephritis, Membranous; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Transplantation Conditioning; Transplantation, Homologous; Vincristine | 2005 |
Unrelated donor bone marrow transplantation without T cell depletion using a chemotherapy only condition regimen. Low incidence of failed engraftment and severe acute GVHD.
Topics: Actuarial Analysis; Acute Disease; Adult; Anti-Infective Agents; Bone Marrow Transplantation; Busulfan; Cause of Death; Critical Care; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Granulocyte-Macrophage Colony-Stimulating Factor; Hematologic Neoplasms; Hepatic Veno-Occlusive Disease; Histocompatibility; HLA-DR Antigens; Humans; Immunosuppressive Agents; Infections; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Risk; Survival Analysis; T-Lymphocytes; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 1996 |
Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Ciprofloxacin; Cyclophosphamide; Estrogens; Female; Genetic Diseases, Inborn; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Incidence; Life Tables; Liver Diseases; Liver Function Tests; Male; Methotrexate; Middle Aged; Multiple Organ Failure; Multivariate Analysis; Neoplasms; Progestins; Retrospective Studies; Risk Factors; Transplantation Conditioning; Vancomycin | 1996 |
Serum interleukin-12 levels in patients undergoing allogeneic or autologous bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Infections; Interleukin-12; Male; Methotrexate; Middle Aged; Transplantation, Autologous; Transplantation, Homologous | 1996 |
[Severe hepatic veno-occlusive disease (VOD) which was successfully treated with supportive therapy, but subsequently developed late-recurrence].
Topics: Adult; Bone Marrow Transplantation; Busulfan; Chronic Disease; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Recurrence; Respiratory Distress Syndrome; Tacrolimus | 1998 |
A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.
Topics: Adult; Anemia, Refractory, with Excess of Blasts; Antilymphocyte Serum; Bone Marrow; Busulfan; Cell Count; Chromosomes, Human, Pair 7; Cyclophosphamide; Disease-Free Survival; Feasibility Studies; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Histocompatibility; Humans; Infections; Karyotyping; Methotrexate; Middle Aged; Monosomy; Myelodysplastic Syndromes; Recurrence; Survival Rate; T-Lymphocytes; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2001 |
Induction of hepatic veno-occlusive disease in dogs.
Topics: Animals; Busulfan; Buthionine Sulfoximine; Cyclophosphamide; Disease Models, Animal; Dog Diseases; Dogs; Hepatic Veno-Occlusive Disease; Liver; Melphalan; Methionine Sulfoximine; Methotrexate; Monocrotaline; Pyrrolizidine Alkaloids; Radiation Injuries, Experimental; Radiography | 1987 |